Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.

Journal of Neuro-oncology
L PoetschPOLA network

Abstract

Approximately 10% of IDH-mutant gliomas harbour non-canonical IDH mutations (non-p.R132H IDH1 and IDH2 mutations). The aim of this study was to analyse the characteristics of non-canonical IDH-mutant gliomas. We retrospectively analysed the characteristics of 166 patients with non-canonical IDH mutant gliomas and compared them to those of 155 consecutive patients with IDH1 p.R132H mutant gliomas. The median age at diagnosis was 38 years in patients with non-canonical IDH mutant gliomas and 43 years in glioma patients with IDH1 p.R132H-mutant tumours. Family history of cancer was more frequent among glioma patients harbouring non-canonical IDH mutations than in patients with IDH1 p.R132H mutations (22.2% vs 5.1%; P < 0.05). Tumours were predominantly localised in the frontal lobe regardless of the type of IDH mutation. Compared to IDH1 p.R132H-mutant gliomas, tumours with non-canonical IDH mutations were more frequently found in the infratentorial region (5.5% vs 0%; P < 0.05) and were often multicentric (4.8% vs 0.9%; P < 0.05). Compared to IDH1 P.R132H-mutant gliomas, tumours with non-canonical IDH1 mutations were more frequently astrocytomas (65.6% vs 43%, P < 0.05), while those with IDH2 mutations were more frequently oligod...Continue Reading

References

Oct 10, 2006·Revue neurologique·K AuréM Sanson
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Feb 13, 2010·Neuro-oncology·Athanassios P KyritsisChrissa Sioka
Aug 13, 2013·Brain Tumor Pathology·Jiro AkimotoMichihiro Kohno
Jun 11, 2015·The New England Journal of Medicine·Jeanette E Eckel-PassowRobert B Jenkins
Apr 3, 2016·Acta Neuropathologica Communications·Charlotte BonnetFrançois Ducray
Aug 31, 2016·Acta Neuropathologica·Emeline TabouretUNKNOWN For POLA Network
Feb 16, 2017·Neuro-oncology·David MeyronetFrançois Ducray
Mar 31, 2017·Journal of Neuro-oncology·Steve BraunsteinDaphne Haas-Kogan
May 10, 2017·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Gliomas

❮ Previous
Next ❯

Citations

Mar 7, 2021·Diagnostics·Enrico FranceschiAlba Ariela Brandes
Oct 1, 2021·Acta Neuropathologica Communications·Alexander H C W Agopyan-MiuGuy M McKhann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.